| RS2544730531 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544730849 |
CCDC88A
|
Health Risk |
Likely pathogenic |
— |
| RS2544731000 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544732273 |
PKD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2544732354 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544733084 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2544733268 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544733362 |
DACT1
|
Health Risk |
Pathogenic |
Townes-Brocks syndrome 2, Townes-Brocks syndrome 2 |
| RS2544733475 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544733512 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS2544733556 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS2544736793 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS2544737008 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544737112 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544737764 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544737997 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease |
| RS2544741352 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544742014 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544742591 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544742790 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS2544742995 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544743555 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544743893 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544744105 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544744207 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544744482 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544744667 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2544745075 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544745312 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2544745346 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-Biallelic Autosomal Recessive Polycystic Kidney Disease, PKD1-Biallelic Autosomal Recessive Polycystic Kidney Disease |
| RS2544745408 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544745465 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544745612 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544745650 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2544747443 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2544747516 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544747563 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544747849 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544747869 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544747871 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544747909 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544748073 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2544749725 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544749730 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544749809 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544749912 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2544749921 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544749971 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544750005 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544750017 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544750037 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544750159 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2544750196 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544750204 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544752143 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544752296 |
GMPPB
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS2544753081 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544753100 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544753151 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544753178 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544753194 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544753209 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544753236 |
CCDC88A
|
Health Risk |
Likely pathogenic |
— |
| RS2544753242 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544753293 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544753339 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2544753552 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2544753646 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544753764 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2544753794 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544753930 |
GMPPB
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS2544753973 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544754093 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544754097 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544754124 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2544754165 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544754190 |
NF1
|
Health Risk |
Likely pathogenic |
Juvenile myelomonocytic leukemia, Juvenile myelomonocytic leukemia |
| RS2544754204 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2544754244 |
RPGRIP1L
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2544754396 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2544756965 |
GMPPB
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS2544757259 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544757590 |
GMPPB
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2T, Autosomal recessive limb-girdle muscular dystrophy type 2T |
| RS2544758303 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544768869 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544769485 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544769929 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544770043 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544772874 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS2544775052 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
PKD1-related disorder, Polycystic kidney disease |
| RS2544775084 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544775146 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS2544775519 |
CACNA1G
|
Health Risk |
Likely pathogenic |
— |
| RS2544776076 |
CACNA1G
|
Health Risk |
Likely pathogenic |
— |
| RS2544776290 |
PKD1
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2544776487 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2544776491 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS2544777318 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, Polycystic kidney disease |
| RS2544777388 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS2544777576 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |